Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer

Abstract

Multimodal treatment leads to relief of symptoms in most patients, and is associated with good survival rates in those able to complete the schedule. [Correction added on 12 February 2020, after first online publication: the Conclusion has been reworded for clarity].